Navigation Links
Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
Date:6/2/2008

SOUTH SAN FRANCISCO, Calif., June 2 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will host a conference call with simultaneous webcast to discuss the preliminary results of its Phase 2 clinical study of R788, a novel, oral Syk kinase inhibitor, in patients with B-cell non-Hodgkin's lymphomas on Tuesday, June 3, 2008 at 8:00 a.m. EDT. Participating on the call will be Rigel senior management and the principal investigator on the study, Jonathan Friedberg, M.D., M.S.Sc., Associate Professor of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center.

Conference Call and Webcast Information

To access the live call, please dial 866-356-3095 (domestic) or 617-597-5391 (international) 10 minutes prior to the start time and use the passcode 61157501. A replay of the call will be available, in webcast and podcast formats, at approximately 10:00 a.m. EDT on June 3, 2008 until June 10, 2008. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and use the passcode 11043962. The conference call will also be webcast live and can be accessed from Rigel's website at http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary.

Further information on R788 in B-cell lymphoma is available at Rigel's website: http://www.rigel.com/rigel/lymphoma.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that d
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
2. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
3. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
4. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
5. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
6. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
7. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
8. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
9. PRoFESS(R) Results Announced at XVII European Stroke Conference
10. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
11. Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...ard-winning video clips feature children, parents ... studies, BETHESDA, Md., Oct. 6 /PRNewswire-USNew...cines, research in children saves lives and improv...m the National Institutes of,Health (NIH), "Childr...linicalStudies.nhlbi.nih.gov ), offers parents and...
(Date:10/6/2008)...ata from SONIC Trial Showed REMICADE Therapy is Mo...ucosal Healing Compared with Standard ...la., Oct. 6 /- Data presented for the...th Crohn,s Disease Naive to,Immunomodulators and B...nto,the approach to care of patients with moderate...
(Date:10/6/2008)... - Conference Call Scheduled for 9:00 AM E... -- Dendreon Corporation (Nasdaq:,DNDN) announced ...alysis of,the Phase 3, randomized, double-blind, p...te AdenoCarcinoma Treatment, also known as D9902B)...efficacy of the,investigational active cellular im...
(Date:10/6/2008)...esign Concept of Other Product - Company,s Bioabso...posium, HONG KONG, Oct. 6 /- Data fr...ro-healing stent, OrbusNeich,s Genous Bio-engineer...nscatheter Cardiovascular,Therapeutics symposium, ... M.D., Ph.D., of the Academic Medical Center in,Am...
Breaking Medicine Technology:Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference 15186 1Mens Health Guide for Ages 40 60 Launched by NHS Choices 15182 1Researchers urge ethics guidelines for human genome research 15179 1Researchers urge ethics guidelines for human genome research 15179 2AT 26T Announces Grant to Center on Aging University of Miami Miller School of Medicine 15177 1AT 26T Announces Grant to Center on Aging University of Miami Miller School of Medicine 15177 2AT 26T Announces Grant to Center on Aging University of Miami Miller School of Medicine 15177 3
(Date:10/6/2008)...childhood obesity, researcher notes , ,...s of middle schools have vending machines where sn...s. , The research demonstrates that there are v...those vending machines don,t always have the healt...istered dietitian with the Center for Obesity Rese...
(Date:10/6/2008)...Call/ -- HealthSouth,Corporation (NYSE: HLS ) tod...zed investor meeting in New York City. Presentatio...T at the Grand Hyatt New York, located at,109 E. 4..., 8:00 a.m. Continental Breakfast 8:30 a.m. ...r -- HealthSouth Overview and Industr...
(Date:10/6/2008)...eir family members can take,anonymous online, tele... 6 /PRNewswire-USNewswire/ -- Military life can pr...lies that are unique and,difficult. Some are manag...,worse and one problem can trigger other more seri...gs out to see what is really happening., (Photo: ...
(Date:10/6/2008)... of California, San Diego School of Medicine sugge...s production of a protective chemical normally fou...ns that are a common result of atopic dermatitis, ... by Richard Gallo, M.D., Ph.D., professor of medic...e UCSD School of Medicine and the Dermatology sect...
Breaking Medicine News(10 mins):Health News:Vending Machines Found in Most Middle Schools 2Health News:HealthSouth to Hold Investor Meeting November 10, 2008 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 3Health News:Oral vitamin D may help prevent some skin infections 2
...artmouth Medical School investigators are learning...levels found in drinking water in many areas of th...aper published online on Dec. 2 in the journal Che...ort that three different steroid hormones all show...
... new study finds that the anti-craving drug, Naltr... negative moods and women who are trying to quit s...st step towards individualized medicine, scientist...nicotine addiction and in treatment. Researchers...
...n experimental epilepsy drug, lacosamide, develope... reducing the frequency of seizures in patients// ...n Monday following the results of a phase 3 trial....were presented at the North American Regional Epil...
... Canadian Study finds that adolescence boys are at... the same age.// Researchers have found that the s...before adulthood. Cardiologists say that smoking, ...ome of the factors for the cause of high blood pre...
Other Medicine News:Health News:Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc 2Health News:Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc 3Health News:Teen Boys At Greater Risk To High Blood Pressure Than Girls 2
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: